Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells

<p>Abstract</p> <p>Background</p> <p>Several naturally occurring cationic antimicrobial peptides (CAPs), including bovine lactoferricin (LfcinB), display promising anticancer activities. These peptides are unaffected by multidrug resistance mechanisms and have been show...

Full description

Bibliographic Details
Main Authors: Lindin Inger, Uhlin-Hansen Lars, Fadnes Bodil, Rekdal Øystein
Format: Article
Language:English
Published: BMC 2011-03-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/11/116
id doaj-39dd843e9bfd45ed8d51935803aac153
record_format Article
spelling doaj-39dd843e9bfd45ed8d51935803aac1532020-11-25T00:34:59ZengBMCBMC Cancer1471-24072011-03-0111111610.1186/1471-2407-11-116Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cellsLindin IngerUhlin-Hansen LarsFadnes BodilRekdal Øystein<p>Abstract</p> <p>Background</p> <p>Several naturally occurring cationic antimicrobial peptides (CAPs), including bovine lactoferricin (LfcinB), display promising anticancer activities. These peptides are unaffected by multidrug resistance mechanisms and have been shown to induce a protective immune response against solid tumors, thus making them interesting candidates for developing novel lead structures for anticancer treatment. Recently, we showed that the anticancer activity by LfcinB was inhibited by the presence of heparan sulfate (HS) on the surface of tumor cells. Based on extensive structure-activity relationship studies performed on LfcinB, shorter and more potent peptides have been constructed. In the present study, we have investigated the anticancer activity of three chemically modified 9-mer peptides and the influence of HS and chondroitin sulfate (CS) on their cytotoxic activity.</p> <p>Methods</p> <p>Various cell lines and red blood cells were used to investigate the anticancer activity and selectivity of the peptides. The cytotoxic effect of the peptides against the different cell lines was measured by use of a colorimetric MTT viability assay. The influence of HS and CS on their cytotoxic activity was evaluated by using HS/CS expressing and HS/CS deficient cell lines. The ability of soluble HS and CS to inhibit the cytotoxic activity of the peptides and the peptides' affinity for HS and CS were also investigated.</p> <p>Results</p> <p>The 9-mer peptides displayed selective anticancer activity. Cells expressing HS/CS were equally or more susceptible to the peptides than cells not expressing HS/CS. The peptides displayed a higher affinity for HS compared to CS, and exogenously added HS inhibited the cytotoxic effect of the peptides.</p> <p>Conclusions</p> <p>In contrast to the previously reported inhibitory effect of HS on LfcinB, the present study shows that the cytotoxic activity of small lytic peptides was increased or not affected by cell surface HS.</p> http://www.biomedcentral.com/1471-2407/11/116
collection DOAJ
language English
format Article
sources DOAJ
author Lindin Inger
Uhlin-Hansen Lars
Fadnes Bodil
Rekdal Øystein
spellingShingle Lindin Inger
Uhlin-Hansen Lars
Fadnes Bodil
Rekdal Øystein
Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
BMC Cancer
author_facet Lindin Inger
Uhlin-Hansen Lars
Fadnes Bodil
Rekdal Øystein
author_sort Lindin Inger
title Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
title_short Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
title_full Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
title_fullStr Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
title_full_unstemmed Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
title_sort small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2011-03-01
description <p>Abstract</p> <p>Background</p> <p>Several naturally occurring cationic antimicrobial peptides (CAPs), including bovine lactoferricin (LfcinB), display promising anticancer activities. These peptides are unaffected by multidrug resistance mechanisms and have been shown to induce a protective immune response against solid tumors, thus making them interesting candidates for developing novel lead structures for anticancer treatment. Recently, we showed that the anticancer activity by LfcinB was inhibited by the presence of heparan sulfate (HS) on the surface of tumor cells. Based on extensive structure-activity relationship studies performed on LfcinB, shorter and more potent peptides have been constructed. In the present study, we have investigated the anticancer activity of three chemically modified 9-mer peptides and the influence of HS and chondroitin sulfate (CS) on their cytotoxic activity.</p> <p>Methods</p> <p>Various cell lines and red blood cells were used to investigate the anticancer activity and selectivity of the peptides. The cytotoxic effect of the peptides against the different cell lines was measured by use of a colorimetric MTT viability assay. The influence of HS and CS on their cytotoxic activity was evaluated by using HS/CS expressing and HS/CS deficient cell lines. The ability of soluble HS and CS to inhibit the cytotoxic activity of the peptides and the peptides' affinity for HS and CS were also investigated.</p> <p>Results</p> <p>The 9-mer peptides displayed selective anticancer activity. Cells expressing HS/CS were equally or more susceptible to the peptides than cells not expressing HS/CS. The peptides displayed a higher affinity for HS compared to CS, and exogenously added HS inhibited the cytotoxic effect of the peptides.</p> <p>Conclusions</p> <p>In contrast to the previously reported inhibitory effect of HS on LfcinB, the present study shows that the cytotoxic activity of small lytic peptides was increased or not affected by cell surface HS.</p>
url http://www.biomedcentral.com/1471-2407/11/116
work_keys_str_mv AT lindininger smalllyticpeptidesescapetheinhibitoryeffectofheparansulfateonthesurfaceofcancercells
AT uhlinhansenlars smalllyticpeptidesescapetheinhibitoryeffectofheparansulfateonthesurfaceofcancercells
AT fadnesbodil smalllyticpeptidesescapetheinhibitoryeffectofheparansulfateonthesurfaceofcancercells
AT rekdaløystein smalllyticpeptidesescapetheinhibitoryeffectofheparansulfateonthesurfaceofcancercells
_version_ 1725311055457943552